Oragenics, Inc. (OGEN) Announces New Strategic Partnership With Mexico-Based Company, Pharmacos Exakta, S.A. de C.V.
11/14/2012 9:50:22 AM
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (OTCQB: OGEN) (OTCBB: OGEN) (the “Company”), a world leader in oral care probiotics, today announced that the Company has entered into a new three year contract agreement with Pharmacos Exakta, S.A. de C.V. Under the terms of the agreement, Pharmacos Exakta will be the exclusive distributor of Oragenics’ oral care probiotics for pets in Mexico under a private label. The pet product will contain ProBiora3®; Oragenics’ patented proprietary blend of three probiotics specifically designed for oral health. Pharmacos Exakta S.A. de C.V. manufactures and markets ophthalmic and other pharmaceutical products for government and private markets. The company was founded in 1957 and is based in Guadalajara, Mexico. As of February 17, 2010, Pharmacos Exakta S.A. de C.V. operates as a subsidiary of Opko Health, Inc.